BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands.
Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, Lisnic B, Dumur CI, Landry JW
Oncotarget. 2017 May 12;8(38):64344-64357. doi: 10.18632/oncotarget.17834. eCollection 2017 Sep 8.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
73665 | pSIREN-RetroQ-shN | pSIREN-RetroQ vector containing control sequence N |
73666 | pSIREN-RetroQ-shLuc | pSRIEN-RetroQ vector containing control sequence luciferase |
73667 | pSIREN-RetroQ-BPTF-sh3 | pSIREN-RetroQ vector containing shRNA sequence to BPTF |
83045 | pSIREN-RetroQ-BPTF-sh5 | MMLV LTR plasmid pSIREN-RetroQ-BPTF-sh5 |
83046 | pLVTHM-shN | Control shRNA pLVTHM-shN |
83275 | pAd388-shLuc | shRNA targeting luciferace |
83276 | pAd388-BPTF-sh28 | shRNA targeting BPTF |
83277 | pLVTHM-Bptf-sh5 | shRNA targeting BPTF |
83278 | pLVTHM-Bptf-sh28 | shRNA targeting BPTF |
92033 | pSIREN-RetroQ-HSPE-sh1 | pSIREN-RetroQ vector containing shRNA sequence to HPSE |
92034 | pSIREN-RetroQ-HSPE-sh2 | pSIREN-RetroQ vector containing shRNA sequence to HPSE |